Navigation Links
Inherited Orphan Blood Disorders Therapeutics Market to 2019 - Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet Need
Date:1/29/2013

>Figure 5: Sickle Cell Anemia, US, Revenue Forecast ($m), 2011–2019 14

Figure 6: Sickle Cell Anemia, UK, Revenue Forecast ($m), 2011–2019 15

Figure 7: Sickle Cell Anemia, France, Revenue Forecast ($m), 2011–2019 15

Figure 8: Sickle Cell Anemia, Germany, Revenue Forecast ($m), 2011–2019 16

Figure 9: Sickle Cell Anemia, Italy, Revenue Forecast ($m), 2011–2019 16

Figure 10: Sickle Cell Anemia, Spain, Revenue Forecast ($m), 2011–2019 17

Figure 11: Sickle Cell Anemia, Total Market, Average Annual Cost of Therapy, 2011–2019 18

Figure 12: Sickle Cell Anemia, Total Market, Treatment Usage Pattern ('000), 2011–2019 19

Figure 13: Hydroxyurea Factsheet 20

Figure 14: Sickle Cell Anemia, Pipeline, Overview 22

Figure 15: Sickle Cell Anemia, Pipeline, Pre-Clinical Molecule Comparison 23

Figure 16: Sickle Cell Anemia, Pipeline, Phase I Molecule Comparison 24

Figure 17: Sickle Cell Anemia, Pipeline, Phase II Molecule Comparison 26

Figure 18: Sickle Cell Anemia, Pipeline, Phase III Molecule Comparison 27

Figure 19: Sickle Cell Anemia, Pipeline by Therapeutic Class 28

Figure 20: Sickle Cell Anemia, Pipeline by Molecule Type 28

Figure 21: Sickle Cell Anemia, Pipeline by Mechanism of Action 29

Figure 22: Hemoglobin Tetramer with ?- and ?-Globulin Chains 33

Figure 23: Global Distribution of ?- and ?-Thalassemia 35

Figure 24: Thalassemia, Total Market, Revenue Forecast ($m), 2011–2019 38

Figure 25: Thalassemia, US, Revenue Forecast ($m), 2011–2019 39

Figure 26: Thalassemia, UK, Revenue Forecast ($m), 2011–2019 39

Figure 27: Thalassemia, France, Revenue Forecast ($m), 2011–2019 40

Figure 28: Thalassemia, Germany'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Savara Pharmaceuticals AeroVanc Granted U.S. Orphan Drug Designation for the Treatment of MRSA Lung Infection in Cystic Fibrosis Patients
2. FDA Grants Orphan Drug Status To Morphoteks Amatuximab (MORAb-009)
3. Albireo Has Been Granted Orphan Drug Designation for A4250 from the US FDA for the Treatment of Progressive Familial Intrahepatic Cholestasis (PFIC) and for Primary Biliary Cirrhosis (PBC)
4. EMA Grants Orphan Designation to Edison Pharmaceuticals for EPI-743 for Treatment of Leigh Syndrome
5. FDA Grants Orphan Drug Designation To GeNO LLC For Use Of Inhaled Nitric Oxide In Treatment Of Persistant Pulmonary Hypertension Of The Newborn (PPHN)
6. Albireo Receives Positive Opinion for Orphan Drug Designation for A4250 for Severe Liver Diseases
7. Grifols Initiates Safety Study of Inhaled Alpha1-Proteinase Inhibitor (Human) Following Orphan Drug Designation for Cystic Fibrosis
8. European Commission Grants Orphan Medicinal Product Designation for Emmaus Medicals Sickle Cell Treatment
9. CSL Behring Receives FDA Orphan Drug Designation for rIX-FP, a Novel Therapy in Development to Treat Congenital Factor IX Deficiency (Hemophilia B)
10. Tris Pharma Announces Approval of First-Ever Generic to Delsym® Dextromethorphan Polistirex Extended-Release Suspension
11. Perrigo Announces FDA Final Approval Of Tris Pharmas Dextromethorphan Polistirex Extended-Release Oral Suspension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... , May 4, 2015 Concord Medical Services Holdings ... leading specialty hospital management solution provider and operator of the ... China , announced today that an Extraordinary General ... 10:00 a.m. ( Beijing time) at CCM,s ... 3rd Ring Road East, Dongcheng District, Beijing, P.R. ...
(Date:5/4/2015)... 2015  Caris Life Sciences®, a leading biotechnology ... medicine, today announced the designation of MedStar Health ... Caris Centers of Excellence for Precision Medicine Network™ ... Maryland and the Washington, ... in oncology research and treatment, with MedStar Georgetown ...
(Date:5/4/2015)... , TX and VANCOUVER , May 4, ... (TSX-V: EPI) announced today that it has received notification from ... the US that the Company,s IND application, filed March 31, ... the FDA of additional chemistry and pharmaceutical data related to ... a Certificate of Analysis on drug product. The ...
Breaking Medicine Technology:Concord Medical Services Announces 2015 Extraordinary General Meeting of Shareholders 2Caris Life Sciences Designates MedStar Health a Caris Center of Excellence 2Caris Life Sciences Designates MedStar Health a Caris Center of Excellence 3ESSA Pharma Inc. Receives FDA Response on IND Application 2ESSA Pharma Inc. Receives FDA Response on IND Application 3ESSA Pharma Inc. Receives FDA Response on IND Application 4
... , HOUSTON, Oct. 5 PAC, a leading global ... process applications, announces the introduction of the ANTEK MultiTek(TM) ... sulfur , nitrogen, and halides. Industries include ... Pharmaceutical, Environmental, and many more. , "MultiTek(TM) is ...
... , SAN DIEGO, Oct. 2 Pharmatek Laboratories, Inc., ... pharmaceutical industry, announced that it is the first CRO ... enhancing the company,s preclinical and early phase clinical GMP ... to move our customers, drug candidates into the clinic ...
Cached Medicine Technology:New ANTEK MultiTek(TM) by PAC Provides Fast, All-in-One Testing for Sulfur, Nitrogen, Halides 2Pharmatek Laboratories Announces Acquisition of the First Xcelodose(R) 600S System on the West Coast 2
(Date:5/4/2015)... Louis, Missouri (PRWEB) May 04, 2015 ... recognized as the “Gateway to the West,” so it ... “Gateway for Veterans Program”, says Dr. Ben Litalien, Chief ... International Franchise Association’s VetFran program and will provide veterans ... , Zerorez® is proud to have a number ...
(Date:5/3/2015)... Birmingham, Lake Orion, Clarkston, Metamora, Michigan (PRWEB) May 03, 2015 ... . She has worked to enhance the well being of ... as a generalist in a hospital, followed by providing care for ... I worked with as an Adult Nurse Practitioner began wondering if ... coupled with the birth of my own children with my mentor ...
(Date:5/3/2015)... 03, 2015 " Bubbly Walrus ” was ... takes a look at the latest and coolest applications on ... host of AppWatch and technology expert, conducted the app review ... educational game. , The best games to play on smartphones ... of users killing brain cells with a video game that ...
(Date:5/3/2015)... 03, 2015 NuevaCare announced today that ... upcoming area seminars. The first event will take place ... Stroke Conference to be held at The Magnolia of ... May 13 during the Dementia Conference to be held ... seminars offer an excellent opportunity to learn about the ...
(Date:5/2/2015)... one of only 30 Illinois companies to be a ... Recognition Program (SHARP) certification, Essentra Specialty Tapes ... of Labor to host this special event. The ... Occupational Safety and Health Administration’s (“OSHA”) Onsite Consultation Program ... exceed all of the necessary regulations and standards, thanks ...
Breaking Medicine News(10 mins):Health News:Zerorez® Creates “Gateway” for Veterans--Announces VetFran Participation. Plans Expansion into the St. Louis Region. 2Health News:Zerorez® Creates “Gateway” for Veterans--Announces VetFran Participation. Plans Expansion into the St. Louis Region. 3Health News:Women's Excellence In Midwifery Welcomes Barbara Crone 2Health News:An Application to Have Fun with Mathematics Was Featured on NewsWatch Television 2Health News:NuevaCare Introduces MnemeTherapy® Approach to Care for Elderly Patients with Alzheimer’s, Stroke and Other Types of Neurodegenerative Conditions 2Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 2Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 3
... ... the 62nd Annual Conference of the Society for Human Resources Management (SHRM). During the ... integration to Human Resource and Payroll professionals at Booth #531 , ... Monterey Park, Calif. (Vocus) June 25, ...
... wine, grapes, blueberries, peanuts and other plants stops ... vision researchers at Washington University School of Medicine in ... vision in blinding eye diseases such as diabetic retinopathy ... in Americans over 50. The formation of new ...
... ... first patent pending method that allows for significant risk reduction for index ... the losses significantly limited or capped while reinvesting index gains accrued to ... Effect." Between 95-100% of the principal value is invested and backed by ...
... ... Values While Creating an Engaged Workforce, , ... Charlotte, NC (Vocus) June 24, 2010 -- ... “Managing the Paradox of Employee Alignment and Engagement.” The free hour-long webinar ...
... HealthDay Reporter , THURSDAY, June 24 (HealthDay News) ... the risk of invasive breast cancer by around 30 ... is considering bisphosphonate use for bone, this might be ... clinical oncologist at the Los Angeles Biomedical Research Institute ...
... trial of a novel radioactive compound readily and safely ... volunteers on brain scans and opens the doors to ... their own radioactive compounds. The results, reported by a ... Nuclear Medicine, could lead to better ways to ...
Cached Medicine News:Health News:NOVAtime participates in the Society for Human Resources Management, (SHRM) 62nd Annual Conference in San Diego, California between June 27 and June 29, 2010 2Health News:NOVAtime participates in the Society for Human Resources Management, (SHRM) 62nd Annual Conference in San Diego, California between June 27 and June 29, 2010 3Health News:Ingredient in red wine may prevent some blinding diseases 2Health News:Ingredient in red wine may prevent some blinding diseases 3Health News:Principal Protected Index Investing Provides Innovative Method to Significantly Reduce Stock Market Loss and Risk 2Health News:Principal Protected Index Investing Provides Innovative Method to Significantly Reduce Stock Market Loss and Risk 3Health News:Morehead Presents Webinar on “Managing the Paradox of Employee Alignment and Engagement”, 2Health News:Bone-Building Pills Appear to Lower Invasive Breast Cancer Risk 2Health News:Bone-Building Pills Appear to Lower Invasive Breast Cancer Risk 3Health News:Novel radiotracer shines new light on the brains of Alzheimer's disease patients 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: